ACF5956 · Advanced Financial Accounting
Accounting for Intangible Assets
ACF5956 Advanced Financial Accounting at Monash University devotes one of its most judgement-heavy weeks to AASB 138 Intangible Assets — the value that sits on a balance sheet without any physical substance. An intangible is an identifiable, non-monetary asset without physical substance, and the whole chapter turns on one bright line: a purchased intangible (a patent, a licence, a brand you buy) is capitalised, while most internally generated value (in-house brands, training, advertising, goodwill, research) cannot be recognised. From there the standard splits research from development via the six PIRATE criteria, decides amortisation versus impairment by useful life, and treats acquired goodwill as a never-amortised residual. It is examinable as theory feeding the 25-mark theory question, and the capitalise-versus-expense classification is a recurring pattern.
What this chapter covers
- 011. The AASB 138 definition — identifiable, non-monetary, no physical substance, plus control and reliable cost
- 022. Recognition criteria — why a valuable item with no reliable cost still fails the test
- 033. The bright line — purchased/acquired intangibles capitalise, internally generated ones expense
- 044. Research vs development — research always expensed, development capitalised only if all six PIRATE criteria are met
- 055. Capping capitalised development at the expected future benefit and expensing the excess
- 066. Subsequent measurement — amortise a finite life, impairment-test an indefinite life
- 077. Amortising a patent over the shorter of its legal life and its useful life
- 088. Goodwill — acquired-only, never amortised, impairment-tested annually and never reversed
R&D and a purchased patent — classify, cap, capitalise and amortise
- +1Research → expense, always. The $110,000 of research is expensed as incurred; AASB 138 prohibits capitalising research because the future benefits are too uncertain to be an asset.
- +1Development → capitalise, but cap it at the expected benefit. PIRATE is satisfied, so development qualifies — but only up to the expected future benefit of $360,000. The excess $420,000 − $360,000 = $60,000 is expensed in the same year.
- +1Year-1 R&D journal: Dr Research expense $110,000; Dr Deferred development costs (asset) $360,000; Dr Development expense $60,000; Cr Cash / payables $530,000.
- +1Patent acquisition (start of Year 2): Dr Patent $960,000 / Cr Cash $960,000 — a separately purchased, identifiable intangible with a reliable cost, so it is capitalised.
- +1Amortise the deferred development once the product is available for use: $360,000 ÷ 6 years = $60,000 per year (Dr Amortisation expense / Cr Accumulated amortisation).
- +1Amortise the patent over the shorter of its legal life (12 years) and its useful life (8 years). There is no resale and no residual, so use 8 years: $960,000 ÷ 8 = $120,000 per year — not the 12-year legal life.
- +1Total amortisation hitting Year-2 profit = $60,000 (development) + $120,000 (patent) = $180,000, on top of the Year-1 research and excess-development expenses of $110,000 + $60,000.
Key terms
- Intangible asset (AASB 138)
- An identifiable, non-monetary asset without physical substance. To be recognised it must also be controlled by the entity, be expected to generate probable future economic benefits, and have a cost that can be measured reliably.
- Identifiability
- An asset is identifiable when it is either separable (able to be sold, licensed or transferred on its own) or it arises from contractual or legal rights. This is the test that internally generated goodwill fails, because it cannot be separated from the business as a whole.
- Purchased vs internally generated
- A purchased or acquired intangible (a bought patent, licence or brand) is capitalised because the arm's-length price is reliable evidence of cost. Most internally generated intangibles — in-house brands, mastheads, customer lists, training and advertising — are expensed because their cost cannot be reliably separated from the cost of running the business.
- Research vs development
- Research is original, planned investigation for new knowledge and is always expensed as incurred. Development applies research findings to a plan or design for a new product or process and is capitalised, but only if all six PIRATE criteria are demonstrated.
- PIRATE
- The six criteria a firm must meet before development costs can be capitalised: Probable future economic benefits, Intention to complete, Resources to complete, Able to use or sell it, Technical feasibility of completion, and Expenditure reliably measurable. Miss any one and the spend is expensed.
- Amortisation
- The systematic write-off of a finite-life intangible over its useful life, usually straight-line to a residual value assumed to be zero. A patent is amortised over the shorter of its legal life and its expected useful life.
- Recoverable amount
- The higher of an asset's value-in-use and its fair value less costs of disposal. An intangible can never be carried above its recoverable amount; if carrying amount exceeds it, an impairment loss is recognised.
- Goodwill
- The excess of the consideration in a business combination over the fair value of the identifiable net assets acquired. Only acquired goodwill is recognised; it is not amortised but is impairment-tested at least annually, and a goodwill impairment is never reversed. Internally generated goodwill is never recognised.
Accounting for Intangible Assets FAQ
Can AI help me with accounting for intangible assets?
Yes — ask Sia to walk through any accounting for intangible assets problem or concept step by step, the way Monash University tests it.
What is the difference between research and development under AASB 138?
Research is original, planned investigation aimed at gaining new knowledge, and it is always expensed as incurred because the future benefits are too uncertain to be an asset. Development applies research findings to a plan or design for a new product or process, and it is capitalised — but only if the firm can demonstrate all six PIRATE criteria (probable benefits, intention to complete, resources, ability to use or sell, technical feasibility, and reliably measurable expenditure). Only spend incurred after the criteria are met can be capitalised; research can never be reclassified as development.
Why can't internally generated brands and goodwill be capitalised?
Because their cost cannot be reliably separated from the cost of running the business. A brand or reputation a firm builds in-house has no reliable, separable cost, so AASB 138 bars it — even though it may be very valuable. The same brand bought from another entity is capitalised, because the purchase price is reliable evidence of cost. The classic exam trap pairs a purchased brand with an internally generated one on the same list to test whether you see that the accounting depends on how the firm got the asset, not what it is.
How do you cap capitalised development at the expected future benefit?
Even when PIRATE is satisfied, the amount capitalised cannot exceed the expected future economic benefit of the project. If a firm spends $420,000 on qualifying development but the project is only expected to generate $360,000 of benefit, you capitalise $360,000 as a deferred development asset and expense the $60,000 excess in the same year. Capitalising the whole $420,000 is a favourite marker's trap because it also throws out every downstream amortisation figure.
Over what life is a patent amortised?
Over the shorter of its legal life and its expected useful life. If a patent has a 12-year legal life but the company only intends to use it for 8 years and will not resell it, you amortise the cost over 8 years, not 12. The residual value is assumed to be zero unless there is a committed buyer or an active market. Using the longer legal life is a common slip that overstates the asset and understates the annual amortisation.
How is goodwill treated differently from other intangibles?
Only acquired goodwill — the residual when one entity buys another for more than the fair value of its identifiable net assets — is recognised; internally generated goodwill is never recognised. Goodwill is not amortised because its life is treated as indefinite; instead it is impairment-tested at least annually at the level of the cash-generating unit it belongs to, and a goodwill impairment loss is never reversed. An answer that spreads goodwill straight-line over 20 years is describing the old pre-2005 regime and is wrong now.
Studying with AI? Sia — free AI accounting tutor works through ACF5956 step by step.
Exam move
Intangibles is a classification-and-method topic, so drill the bright line until it is automatic. For any list of outlays, decide purchased-or-internally-generated first: bought identifiable intangibles capitalise, internally generated brands, training, advertising, research and goodwill expense — and give a one-line reason per item, which is what earns the mark rather than a paragraph. For the R&D numbers, practise the pipeline on fresh figures every time: expense research, capitalise development only if all six PIRATE criteria are met, cap the capitalised amount at the expected future benefit and expense the excess, then amortise the deferred development over the benefit period and any patent over the shorter of its legal and useful life. Keep a checklist of the traps that quietly cost marks: capitalising the whole development spend instead of capping it, amortising a patent over the legal life, capitalising research or an internally generated brand, and describing goodwill as amortised rather than impairment-tested. Structure every answer STATE the rule → APPLY to the facts → CONCLUDE with the figure or journal, and remember the exam is closed-book. Ask Sia to set you classification lists and R&D problems with different benefit, life and ownership assumptions and to mark your journals line by line.
